MS vs PG: Which Is the Better Buy?

Side-by-side comparison of Morgan Stanley and The Procter & Gamble Company β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-04.
Morgan Stanley Β· Financial Services
$189.30
-30.5% upside to fair value
Grade C High Quality
VS
The Procter & Gamble Company Β· Consumer Defensive
$143.45
+13.8% upside to fair value
Grade B High Quality
QuantHub Verdict
PG has more upside to fair value (+13.8%). MS trades at a lower forward P/E (16.4x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MS PG
Current Price $189.30 $143.45
Fair Value Estimate $131.49 $163.27
Upside to Fair Value -30.5% +13.8%
Market Cap $300.6B $334.0B
Forward P/E 16.4x 20.8x
EV / EBITDA 24.4x 15.4x
Price / Sales 2.5x 3.9x
Price / FCF -16.8x 22.2x
Revenue Growth YoY +18.8% +7.4%
Gross Margin 58.0% 50.3%
Operating Margin 19.5% 23.2%
Return on Equity 16.7% 31.3%
Dividend Yield 0% 0%
FCF Yield β€” 4.5%
Analyst Consensus Hold Buy
Investment Thesis
MS β€” Morgan Stanley
Morgan Stanley is a leading global financial services firm operating in Institutional Securities, Wealth Management, and Investment Management. The company benefits from a durable competitive moat supported by its systemically important status, diversified revenue streams, and strong management with a 36-year veteran CEO. Despite solid fundamentals including 14.2% revenue growth in 2025 and 16.7%…
PG β€” The Procter & Gamble Company
The Procter & Gamble Company is a leading consumer defensive firm specializing in household and personal products with a diversified portfolio across fabric and home care, baby and family care, beauty, health care, and grooming segments. The business quality is high, supported by durable brands, strong margins with a 50.3% gross margin and 19.2% net margin, and consistent earnings growth evidence…
Accumulation Zones
Metric MS PG
Zone Low $98.62 $122.45
Zone High $111.77 $138.78
In Buy Zone? No No
← MS Research    PG Research β†’    All Research